title: Cost analysis of intensive glycemic control in critically ill adult patients.
authors.forename: Jan G
authors.initials: JG
authors.lastname: Zijlstra
authors.forename: Anouk M
authors.initials: AM
authors.lastname: Corstjens
authors.forename: Jaap E
authors.initials: JE
authors.lastname: Tulleken
authors.forename: John H J M
authors.initials: JH
authors.lastname: Meertens
authors.forename: Jack J M
authors.initials: JJ
authors.lastname: Ligtenberg
mesh_terms: D001786:Blood Glucose / Q000378:metabolism*; D003362:Cost-Benefit Analysis; D006801:Humans; D006943:Hyperglycemia / Q000188:drug therapy / Q000191:economics* / Q000401:mortality; D007328:Insulin / Q000191:economics* / Q000627:therapeutic use; D007362:Intensive Care Units / Q000191:economics*; D007902:Length of Stay / Q000191:economics*; D015996:Survival Rate; D016896:Treatment Outcome
chemical_list: D001786:Blood Glucose; D007328:Insulin